Khanna J M, Le A D, Kalant H, LeBlanc A E
Adv Exp Med Biol. 1980;126:181-95. doi: 10.1007/978-1-4684-3632-7_17.
Previously it has been shown that chronic administration of p-chlorophenylalanine (p-CPA), slowed the development of tolerance to ethanol, pentobarbital and cross-tolerance development to ethanol in rats chronically treated with pentobarbital. These findings have been extended by the following observations: (1) p-CPA slowed the development of tolerance to barbital as measured by motor impairment on the moving belt test, without altering the acute response. (2) p-CPA also reduced the tolerance to barbital as measured by sleeping time, in animals chronically treated with pentobarbital. (3) Administration of L-tryptophan increased the rate of tolerance development to ethanol as measured by motor impairment and hypothermia. These results further confirm and extend the generality of our observations that 5-HT may be involved in the development of tolerance and cross-tolerance to sedatives.
此前已有研究表明,长期给予对氯苯丙氨酸(p-CPA)可减缓大鼠对乙醇、戊巴比妥耐受性的发展,以及减缓长期用戊巴比妥处理的大鼠对乙醇交叉耐受性的发展。以下观察结果进一步拓展了这些发现:(1)通过移动带试验中运动障碍来衡量,p-CPA减缓了对巴比妥耐受性的发展,且未改变急性反应。(2)在用戊巴比妥长期处理的动物中,以睡眠时间衡量,p-CPA也降低了对巴比妥的耐受性。(3)给予L-色氨酸可加快以运动障碍和体温过低衡量的对乙醇耐受性的发展速度。这些结果进一步证实并拓展了我们的观察结果,即5-羟色胺可能参与了对镇静剂耐受性和交叉耐受性的发展过程。